Emmanuel B. Bache

1.5k total citations · 1 hit paper
9 papers, 622 citations indexed

About

Emmanuel B. Bache is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Emmanuel B. Bache has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Emmanuel B. Bache's work include Malaria Research and Control (5 papers), Mosquito-borne diseases and control (3 papers) and Pharmaceutical Economics and Policy (2 papers). Emmanuel B. Bache is often cited by papers focused on Malaria Research and Control (5 papers), Mosquito-borne diseases and control (3 papers) and Pharmaceutical Economics and Policy (2 papers). Emmanuel B. Bache collaborates with scholars based in Germany, Gabon and Netherlands. Emmanuel B. Bache's co-authors include Sélidji Todagbé Agnandji, José Francisco Fernandes, Marguerite Massinga Loembé, Bertrand Lell, Ayôla Akim Adégnika, Peter G. Kremsner, Abraham Alabi, Benjamin Gottlieb Mordmüller, Anita L. Kabwende and Saadou Issifou and has published in prestigious journals such as The Lancet, Vaccine and PLoS neglected tropical diseases.

In The Last Decade

Emmanuel B. Bache

9 papers receiving 616 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

2015 478 citations Emmanuel B. Bache, Sélidji Todagbé Agnandji et al. The Lancet profile →

Peers

Countries citing papers authored by Emmanuel B. Bache

Since Specialization

Citations

This map shows the geographic impact of Emmanuel B. Bache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel B. Bache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel B. Bache more than expected).

Fields of papers citing papers by Emmanuel B. Bache

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel B. Bache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel B. Bache. The network helps show where Emmanuel B. Bache may publish in the future.

Co-authorship network of co-authors of Emmanuel B. Bache

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel B. Bache. A scholar is included among the top collaborators of Emmanuel B. Bache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel B. Bache. Emmanuel B. Bache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives 2022 ·Travel Medicine and Infectious Disease ·Jenny L Schnyder, Hanna K de Jong, Emmanuel B. Bache, Reinier M. van Hest, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hänscheid, Martin P. Grobusch	3
2	Complicated Odontogenic Infections at 2 District Hospitals in Tonkolili District, Sierra Leone: Protocol for a Prospective Observational Cohort Study (DELAY) 2021 ·JMIR Research Protocols ·(unknown), Jan Henk Dubbink, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Emmanuel B. Bache, (unknown), Frieder Schaumburg, Fred K. L. Spijkervet, Martin P. Grobusch	1
3	Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections 2021 ·BMC Infectious Diseases ·Yuri Ushijima, Haruka Abe, (unknown), Rodrigue Bikangui, Marguerite Massinga Loembé, (unknown), (unknown), (unknown), Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell, Jiro Yasuda	25
4	A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children 2016 ·Vaccine ·(unknown), Sélidji Todagbé Agnandji, Johannes Elias, (unknown), Emmanuel B. Bache, José Francisco Fernandes, Marguerite Massinga Loembé, Johanna Haß, Bertrand Lell, Benjamin Mordmüller, Ayôla Akim Adégnika, Peter G. Kremsner, Meral Esen	10
5	The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs 2016 ·Malaria Journal ·Benjamin J Visser, Sophia G. de Vries, Emmanuel B. Bache, (unknown), (unknown), (unknown), (unknown), Michèle van Vugt, Martin P. Grobusch	17
6	Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. breakdown → 2015 ·The Lancet ·Emmanuel B. Bache, Sélidji Todagbé Agnandji, Bertrand Lell, José Francisco Fernandes, (unknown), Anita L. Kabwende, Ayôla Akim Adégnika, Benjamin Gottlieb Mordmüller, Peter G. Kremsner, Marguerite Massinga Loembé, Abraham Alabi, Saadou Issifou	478
7	Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial 2015 ·PLoS neglected tropical diseases ·(unknown), Sélidji Todagbé Agnandji, (unknown), Emmanuel B. Bache, José Francisco Fernandes, Brunhilde Schweiger, Marguerite Massinga Loembé, Thomas Engleitner, Bertrand Lell, Benjamin Mordmüller, Ayôla Akim Adégnika, Maria Yazdanbakhsh, Peter G. Kremsner, Meral Esen	24
8	Assessing the quality of anti-malarial drugs from Gabonese pharmacies using the MiniLab®: a field study 2015 ·Malaria Journal ·Benjamin J Visser, (unknown), (unknown), (unknown), (unknown), Emmanuel B. Bache, (unknown), Michèle van Vugt, (unknown), Harparkash Kaur, Martin P. Grobusch	28
9	Clinical Development of RTS,S/AS Malaria Vaccine: A Systematic Review of Clinical Phase I–III Trials 2015 ·Future Microbiology ·Sélidji Todagbé Agnandji, José Francisco Fernandes, Emmanuel B. Bache, Michael Ramharter	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact